Effects of hyperbaric exposure on mechanical and electronic parameters of implantable cardioverter-defibrillators

被引:1
|
作者
Guenneugues, Romain [1 ]
Henckes, Anne [1 ]
Mansourati, Vincent [2 ]
Mansourati, Jacques [2 ]
机构
[1] Univ Hosp Brest, Hyperbar Med Unit, Bvd Tanguy Prigent, F-29609 Brest, France
[2] Univ Hosp Brest, Dept Cardiol, Bvd Tanguy Prigent, F-29609 Brest, France
来源
EUROPACE | 2023年 / 25卷 / 05期
关键词
ICD; Hyperbaric exposure; Hyperbaric oxygen therapy;
D O I
10.1093/europace/euad134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Hyperbaric oxygen therapy (HBOT) is the standard adjuvant treatment for life-threatening or disabling pathologies. Currently, mechanical and electronic variations of implantable cardioverter-defibrillators (ICD) in hyperbaric conditions have not been evaluated. As a result, many patients eligible for HBOT but ICD recipients cannot undergo this therapy, even in emergency situations. Methods and results Twenty-two explanted ICD of various brands and models were randomized in two groups: single hyperbaric exposure at an absolute pressure of 4000 hPa and 30 iterative hyperbaric exposures at an absolute pressure of 4000 hPa. Mechanical and electronic parameters of these ICD were blindly assessed before, during, and after hyperbaric exposures. Regardless of the hyperbaric exposure, we could not find any mechanical distortion, inappropriate occurrence of anti-tachycardia therapies, dysfunction of tachyarrhythmia therapeutic programming, or dysfunction of programmed pacing parameters. Conclusion Dry hyperbaric exposure seems harmless on ICD tested ex vivo. This result may lead to a reconsideration of the absolute contraindication of emergency HBOT to ICD recipients. A real-life study in these patients with an indication to HBOT should be performed to assess their tolerance to the treatment.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Comparison of the Effects of High-Energy Photon Beam Irradiation (10 and 18 MV) on 2 Types of Implantable Cardioverter-Defibrillators
    Hashii, Haruko
    Hashimoto, Takayuki
    Okawa, Ayako
    Shida, Koichi
    Isobe, Tomonori
    Hanmura, Masahiro
    Nishimura, Tetsuo
    Aonuma, Kazutaka
    Sakae, Takeji
    Sakurai, Hideyuki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (03): : 840 - 845
  • [42] Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators
    Peterson, Pamela N.
    Greenlee, Robert T.
    Go, Alan S.
    Magid, David J.
    Cassidy-Bushrow, Andrea
    Garcia-Montilla, Romel
    Glenn, Karen A.
    Gurwitz, Jerry H.
    Hammill, Stephen C.
    Hayes, John
    Kadish, Alan
    Reynolds, Kristi
    Sharma, Param
    Smith, David H.
    Varosy, Paul D.
    Vidaillet, Humberto
    Zeng, Chan X.
    Normand, Sharon-Lise T.
    Masoudi, Frederick A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
  • [43] Remote monitoring to Improve long-term prognosis in heart failure patients with implantable cardioverter-defibrillators
    Ono, Maki
    Varma, Niraj
    EXPERT REVIEW OF MEDICAL DEVICES, 2017, 14 (05) : 335 - 342
  • [44] Static magnetic field measurements of smart phones and watches and applicability to triggering magnet modes in implantable pacemakers and implantable cardioverter-defibrillators
    Seidman, Seth J.
    Guag, Joshua
    Beard, Brian
    Arp, Zane
    HEART RHYTHM, 2021, 18 (10) : 1741 - 1744
  • [45] In vitro tests reveal sample radiofrequency identification readers inducing clinically significant electromagnetic interference to implantable pacemakers and implantable cardioverter-defibrillators
    Seidman, Seth J.
    Brockman, Randall
    Lewis, Brian Marc
    Guag, Joshua
    Shein, Mitchell J.
    Clement, Wesley J.
    Kippola, James
    Digby, Dennis
    Barber, Catherine
    Huntwork, Dan
    HEART RHYTHM, 2010, 7 (01) : 99 - 107
  • [46] Electromagnetic interference with cardiac pacemakers and implantable cardioverter-defibrillators from low-frequency electromagnetic fields in vivo
    Tiikkaja, Maria
    Aro, Aapo L.
    Alanko, Tommi
    Lindholm, Harri
    Sistonen, Heli
    Hartikainen, Juha E. K.
    Toivonen, Lauri
    Juutilainen, Jukka
    Hietanen, Maila
    EUROPACE, 2013, 15 (03): : 388 - 394
  • [47] High-voltage impedance rise; mechanismand management in patients with transvenous implantable cardioverter-defibrillators: a case series
    Monkhouse, Christopher
    Cambridge, Alex
    Chow, Anthony W. C.
    Behar, Jonathan M.
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2019, 3 (04) : 1 - 8
  • [48] Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
    Levy, Wayne C.
    Hellkamp, Anne S.
    Mark, Daniel B.
    Poole, Jeanne E.
    Shadman, Ramin
    Dardas, Todd F.
    Anderson, Jill
    Johnson, George
    Fishbein, Daniel P.
    Lee, Kerry L.
    Linker, David T.
    Bardy, Gust H.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2018, 4 (08) : 1089 - 1102
  • [49] Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
    Braunschweig, Frieder
    Anker, Stefan D.
    Proff, Jochen
    Varma, Niraj
    EUROPACE, 2019, 21 (06): : 846 - 855
  • [50] The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis
    Agrawal, Sahil
    Garg, Lohit
    Nanda, Sudip
    Sharma, Abhishek
    Bhatia, Nirmanmoh
    Manda, Yugandhar
    Singh, Amitoj
    Fegley, Mark
    Shirani, Jamshid
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 379 - 384